Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

John B.A.G. Haanen, Franck Carbonnel, Caroline Robert et al. · Annals of Oncology · 2017 · 2.3K citations

Immunotoxicology, Immunodeficiencies, Immunology +6

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. Johnson, Justin M. Balko, Margaret Compton et al. · New England Journal of Medicine · 2016 · 2.2K citations · Full text

Fatal Myocarditis, Cancer Immunosurveillance, Skeletal Muscle +12

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions

Eugène van Puijenbroek, Andrew Bate, Hubert G.M. Leufkens et al. · Pharmacoepidemiology and Drug Safety · 2002 · 1.2K citations

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

Juan C. Osorio, Ai Ni, Jamie E. Chaft et al. · Annals of Oncology · 2016 · 667 citations · Full text

Antibody-mediated Thyroid Dysfunction, Cancer Immunosurveillance, Non-small-cell Lung Cancer +11

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

Camille Hua, Lise Boussemart, Christine Mateus et al. · JAMA Dermatology · 2015 · 638 citations